143 related articles for article (PubMed ID: 35710734)
1. Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy.
Nitsche C; Mascherbauer K; Calabretta R; Koschutnik M; Dona C; Dannenberg V; Hofer F; Halavina K; Kammerlander AA; Traub-Weidinger T; Goliasch G; Hengstenberg C; Hacker M; Mascherbauer J
J Nucl Med; 2022 Dec; 63(12):1906-1911. PubMed ID: 35710734
[TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
[TBL] [Abstract][Full Text] [Related]
3. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
4. Unveiling Cardiac Amyloidosis, its Characteristics, and Outcomes Among Patients With MR Undergoing Transcatheter Edge-to-Edge MV Repair.
Donà C; Nitsche C; Koschutnik M; Heitzinger G; Mascherbauer K; Kammerlander AA; Dannenberg V; Halavina K; Rettl R; Duca F; Traub-Weidinger T; Puchinger J; Gunacker PC; Lamm G; Vock P; Lileg B; Philipp V; Staudenherz A; Calabretta R; Hacker M; Agis H; Bartko P; Hengstenberg C; Fontana M; Goliasch G; Mascherbauer J
JACC Cardiovasc Interv; 2022 Sep; 15(17):1748-1758. PubMed ID: 36008266
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.
Nitsche C; Scully PR; Patel KP; Kammerlander AA; Koschutnik M; Dona C; Wollenweber T; Ahmed N; Thornton GD; Kelion AD; Sabharwal N; Newton JD; Ozkor M; Kennon S; Mullen M; Lloyd G; Fontana M; Hawkins PN; Pugliese F; Menezes LJ; Moon JC; Mascherbauer J; Treibel TA
J Am Coll Cardiol; 2021 Jan; 77(2):128-139. PubMed ID: 33181246
[TBL] [Abstract][Full Text] [Related]
6. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
Quarta CC; Zheng J; Hutt D; Grigore SF; Manwani R; Sachchithanantham S; Mahmood SA; Whelan CJ; Fontana M; Martinez-Naharro A; Chacko L; Lachmann HJ; Gillmore JD; Rapezzi C; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1304-1311. PubMed ID: 34254119
[TBL] [Abstract][Full Text] [Related]
8. Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
Persia-Paulino YR; Cuevas-Perez J; Fernandez-Asensio R; Junco-Vicente A; Rozado-Castano J; Colunga S; Cigarran H; Calvo J; Laverde A; Persia O; Capin-Sampedro E
J Nucl Cardiol; 2021 Jun; 28(3):1117-1125. PubMed ID: 32333280
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study.
Spielvogel CP; Haberl D; Mascherbauer K; Ning J; Kluge K; Traub-Weidinger T; Davies RH; Pierce I; Patel K; Nakuz T; Göllner A; Amereller D; Starace M; Monaci A; Weber M; Li X; Haug AR; Calabretta R; Ma X; Zhao M; Mascherbauer J; Kammerlander A; Hengstenberg C; Menezes LJ; Sciagra R; Treibel TA; Hacker M; Nitsche C
Lancet Digit Health; 2024 Apr; 6(4):e251-e260. PubMed ID: 38519153
[TBL] [Abstract][Full Text] [Related]
10. Early-phase myocardial uptake intensity of
Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Quantitative
Harapoz M; Evans S; Geenty P; Kwok F; Stewart G; Taylor MS; Farlow D; Thomas L
Heart Lung Circ; 2022 Jun; 31(6):804-814. PubMed ID: 35181228
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis.
Park YJ; Lee J; Kim D; Choi JO; Kim SJ; Kim K; Choi JY
BMC Med Imaging; 2023 Jul; 23(1):92. PubMed ID: 37460984
[TBL] [Abstract][Full Text] [Related]
13. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of
Uusitalo V; Suomalainen O; Loimaala A; Mätzke S; Heliö T
Heart Lung Circ; 2022 May; 31(5):629-637. PubMed ID: 35063379
[TBL] [Abstract][Full Text] [Related]
15. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration.
Rudolphi Solero T; Feriche Aragón M; Amrani Raissouni T; Delgado-García A; Cañada-Rodríguez MJ; Sanz Viedma S
Clin Nucl Med; 2024 Feb; 49(2):e65-e67. PubMed ID: 38048549
[TBL] [Abstract][Full Text] [Related]
16. The Utility of
Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.
Bianco M; Parente A; Biolè C; Righetti C; Spirito A; Luciano A; Destefanis P; Nangeroni G; Angusti T; Anselmino M; Montagna L
J Nucl Cardiol; 2021 Jun; 28(3):825-830. PubMed ID: 33728572
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of
Ross JC; Hutt DF; Burniston M; Page J; Steeden JA; Gillmore JD; Wechalekar AD; Hawkins PN; Fontana M
Amyloid; 2018 Sep; 25(3):203-210. PubMed ID: 30486686
[TBL] [Abstract][Full Text] [Related]
20. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.
Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
